ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Takeda to give foreign directors two-thirds majority on board

Former U.S. EXIM Bank chief and veteran biotech exec nominated for seats

Leading Japanese drugmaker Takeda Pharmaceutical will field a board of directors that features a clear majority of foreign nationals.

TOKYO -- Top Japanese drugmaker Takeda Pharmaceutical has nominated two more foreign nationals as directors, paving the way for non-Japanese officers to hold a two-thirds majority on its board.

Kimberly Reed and John Maraganore,both American citizens, are candidates for outside director seats. The new slate of directors will face a vote at the company's upcoming shareholders' meeting.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more